Efficacy of the NVX-CoV2373 COVID-19 Vaccine in Patients With vs Without HIV
Researchers assessed humoral responses to COVID-19 vaccination with NVX-CoV2373 among patients with vs without HIV infection on the basis of prior COVID-19 exposure.
Researchers assessed humoral responses to COVID-19 vaccination with NVX-CoV2373 among patients with vs without HIV infection on the basis of prior COVID-19 exposure.
Researchers assessed the effectiveness of both sofosbuvir/velpatasvir and gelcaprevir/pibrentasvir among patients infected with hepatitis C genotype 6.
Researchers assessed the influence of intrapartum antibiotic prophylaxis on the emergence of antimicrobial resistant Group B streptococcal isolates.
Researchers assessed the potential for COVID-19 transmission via contaminated surfaces.
Investigators assessed the risk for incident diabetes and hyperglycemia among patients with HIV infection receiving integrase strand transfer inhibitors.
Researchers assessed the prevalence of sexually transmitted infections during pregnancy and factors associated with preterm birth among women with HIV infection.
Presenting at CMSC 2022, researchers evaluated the response to the mRNA-1273 vaccine in patients who received DMTs for MS.
Researchers assessed clinical outcomes among critically ill children who received meropenem treatment via extended infusion vs intermittent bolus.
Researchers assessed the antiviral activity of several antiseptic agents against COVID-19 transmissibility.
Researchers evaluated the effects of nasogastric tube feeding vs careful hand feeding on survival outcomes and the risk for pneumonia among older patients with advanced dementia.